NGD Launches Real-Time Infection Detection at Sheba Medical Center

CAMBRIDGE, Mass., September 23, 2026 /CourierPR/ -- NGD Infection Prevention, a leading provider of end-to-end whole-genome sequencing platforms and bioinformatics solutions, today announced the successful deployment of its fully automated NGD200 system at Sheba Medical Center in Israel. The system, which prepares up to 48 bacterial samples in a single run, is now enabling the real-time detection of the spread of drug-resistant bacterial infections, specifically carbapenem-resistant Enterobacterales (CRE), for use by Sheba's Infection Prevention and Control (IPC) team in guiding interventions to prevent the spread of infections.

The fully automated NGD200 system, which completes every step of the workflow from lysis to extraction to library construction in just four hours, is a significant advancement in the battle against antibiotic-resistant infections. This system is particularly crucial in the Middle East, where the rate of life-threatening carbapenem-resistant infections has increased by 470% over the past five years. The rise in carbapenem-resistant Enterobacterales (CRE) infections has been a serious challenge for hospitals, not only in Israel but also in the United States, where the rate of these infections has surged.

Israel has previously implemented a national strategy to contain the spread of carbapenem-resistant Enterobacterales. The launch of the NGD200 system at Sheba Medical Center reflects NGD's leading role in the United States and globally in providing hospitals with an end-to-end, cost-conscious approach to real-time genomic transmission detection. The system supports efficient sequencing workflows with low hands-on time per sample performed by non-specialized microbiology lab technicians, at the throughput and cost per sample required to use prospective sequencing to detect transmission.

Sheba Medical Center, one of the Middle East's foremost medical centers and among the top 10 worldwide, is highly dedicated and motivated in addressing healthcare-associated and drug-resistant infections. The center's infection-prevention, clinical microbiology, and epidemiological teams work across clinical care and research to address these challenges.

The launch of the NGD200 system at Sheba Medical Center marks a significant step forward in the fight against antibiotic-resistant infections, offering a practical and scalable solution for real-time genomic transmission detection in the hospital environment. This deployment is a testament to NGD's commitment to providing hospitals with the tools they need to combat the growing threat of antibiotic-resistant bacteria.